Search Results

There are 7508 results for: content related to: Use of smell test identification in Parkinson's disease in Mexico: A matched case-control study

  1. Aripiprazole in Bipolar Disorder

    Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition

    Alessandra Nivoli, Eduard Vieta, Pages: 245–269, 2011

    Published Online : 13 APR 2011, DOI: 10.1002/9780470975114.ch12

  2. You have free access to this content
    Aripiprazole: A Novel Atypical Antipsychotic Drug With a Uniquely Robust Pharmacology

    CNS Drug Reviews

    Volume 10, Issue 4, December 2004, Pages: 317–336, Marilyn A Davies, Douglas J. Sheffler and Bryan L. Roth

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2004.tb00030.x

  3. Aripiprazole, a Novel Atypical Antipsychotic Drug

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 2, February 2004, Pages: 212–228, Tami R. Argo, Ryan M. Carnahan and Dr. Paul J. Perry

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.24.2.212.33145

  4. Aripiprazole and its human metabolite OPC14857 reduce, through a presynaptic mechanism, glutamate release in rat prefrontal cortex: Possible relevance to neuroprotective interventions in schizophrenia

    Synapse

    Volume 62, Issue 11, November 2008, Pages: 804–818, Tsung-Tsair Yang and Su-Jane Wang

    Version of Record online : 20 AUG 2008, DOI: 10.1002/syn.20548

  5. Use of aripiprazole for delirium in the elderly: a short review

    Psychogeriatrics

    Volume 15, Issue 1, March 2015, Pages: 75–84, Eiji Kirino

    Version of Record online : 17 DEC 2014, DOI: 10.1111/psyg.12088

  6. A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder

    Human Psychopharmacology: Clinical and Experimental

    Volume 24, Issue 2, March 2009, Pages: 145–152, Frank C Schieber, David W Boulton, Alfred H Balch, Robert Croop, Suresh Mallikaarjun, Jeannine Benson and Berit X Carlson

    Version of Record online : 8 JAN 2009, DOI: 10.1002/hup.999

  7. Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392)

    Bipolar Disorders

    Volume 14, Issue 1, February 2012, Pages: 41–53, Berit X Carlson, Terence A Ketter, Wei Sun, Karen Timko, Robert D McQuade, Raymond Sanchez, Estelle Vester-Blokland and Ronald Marcus

    Version of Record online : 13 FEB 2012, DOI: 10.1111/j.1399-5618.2011.00974.x

  8. Pharmacokinetics, Tolerability, and Safety of Aripiprazole following Multiple Oral Dosing in Normal Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 44, Issue 2, February 2004, Pages: 179–187, Dr. Suresh Mallikaarjun, Dr. Daniel E. Salazar and Dr. Steven L. Bramer

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003261901

  9. Lack of a pharmacokinetic drug–drug interaction between lithium and valproate when co-administered with aripiprazole

    Journal of Clinical Pharmacy and Therapeutics

    D. W. Boulton, G. D. Kollia, S. Mallikaarjun and D. M. Kornhauser

    Version of Record online : 14 MAY 2012, DOI: 10.1111/j.1365-2710.2012.1331.x

  10. Lack of a pharmacokinetic drug–drug interaction between lithium and valproate when co-administered with aripiprazole

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 5, October 2012, Pages: 565–570, D. W. Boulton, G. D. Kollia, S. Mallikaarjun and D. M. Kornhauser

    Version of Record online : 3 SEP 2012, DOI: 10.1111/j.1365-2710.2012.01331.x

  11. Pharmacokinetics of Aripiprazole and Concomitant Lithium and Valproate

    The Journal of Clinical Pharmacology

    Volume 45, Issue 1, January 2005, Pages: 89–93, Dr Leslie Citrome, Dr Richard Josiassen, Dr Nigel Bark, Dr Daniel E. Salazar and Dr Suresh Mallikaarjun

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270004269870

  12. Tardive dyskinesia and other movement disorders secondary to aripiprazole

    Movement Disorders

    Volume 26, Issue 1, January 2011, Pages: 147–152, Maria Sierra Peña, Toby C. Yaltho and Joseph Jankovic

    Version of Record online : 3 SEP 2010, DOI: 10.1002/mds.23402

  13. You have free access to this content
    Unique Pharmacological Profile of a Novel Antipsychotic Drug, Aripiprazole (OPC-14597)

    CNS Drug Reviews

    Volume 3, Issue 1, March 1997, Pages: 24–33, Masashi Sasa and Taku Amano

    Version of Record online : 29 SEP 2006, DOI: 10.1111/j.1527-3458.1997.tb00314.x

  14. You have free access to this content
    Efficacy of aripiprazole augmentation in Japanese patients with major depressive disorder: A subgroup analysis and Montgomery–Åsberg Depression Rating Scale and Hamilton Rating Scale for Depression item analyses of the Aripiprazole Depression Multicenter Efficacy study

    Psychiatry and Clinical Neurosciences

    Volume 69, Issue 1, January 2015, Pages: 34–42, Norio Ozaki, Tempei Otsubo, Masaki Kato, Teruhiko Higuchi, Hiroaki Ono, Kunitoshi Kamijima and ADMIRE Study Group

    Version of Record online : 4 AUG 2014, DOI: 10.1111/pcn.12214

  15. Global benefit–risk analysis of adjunctive aripiprazole in the treatment of patients with major depressive disorder

    Pharmacoepidemiology and Drug Safety

    Volume 18, Issue 10, October 2009, Pages: 965–972, Stephen R. Wisniewski, PhD, Chi-Chang Chen, PhD, Edward Kim, MD, MBA, Hong J. Kan, PhD, Zhenchao Guo, PhD, Berit X. Carlson, PhD, Quynh-Van Tran, Pharm D, BCPP and Andrei Pikalov, MD, PhD

    Version of Record online : 6 AUG 2009, DOI: 10.1002/pds.1805

  16. Silent saliva aspiration in Parkinson's disease

    Movement Disorders

    Volume 26, Issue 1, January 2011, Pages: 138–141, Bernardo Rodrigues, Ana Caline Nóbrega, Marília Sampaio, Natalie Argolo and Ailton Melo

    Version of Record online : 16 NOV 2010, DOI: 10.1002/mds.23301

  17. Cerebrospinal fluid tau and phosphorylated tau protein are elevated in corticobasal syndrome

    Movement Disorders

    Volume 26, Issue 1, January 2011, Pages: 169–173, M.B. Aerts, R.A.J. Esselink, B.R. Bloem and M.M. Verbeek

    Version of Record online : 10 SEP 2010, DOI: 10.1002/mds.23341

  18. EFFECTS OF ARIPIPRAZOLE AUGMENTATION IN TREATMENT-RESISTANT OBSESSIVE-COMPULSIVE DISORDER (A DOUBLE BLIND CLINICAL TRIAL)

    Depression and Anxiety

    Volume 29, Issue 10, October 2012, Pages: 850–854, Mehdi Sayyah, Mohammad Sayyah, Hatam Boostani, Seyyed Mohammad Ghaffari and Abedin Hoseini

    Version of Record online : 29 AUG 2012, DOI: 10.1002/da.21996

  19. Response and remission rates with adjunctive aripiprazole in patients with major depressive disorder who exhibit minimal or no improvement on antidepressant monotherapy

    International Journal of Clinical Practice

    Volume 68, Issue 11, November 2014, Pages: 1301–1308, D. E. Casey, K. K. Laubmeier, J. M. Eudicone, R. Marcus, R. M. Berman, Z. Rahman and J. Sheehan

    Version of Record online : 6 SEP 2014, DOI: 10.1111/ijcp.12480

  20. Excessive Somnolence from Aripiprazole in a Child

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 4, April 2004, Pages: 522–525, Jennifer D. Davenport, Michelle W. McCarthy and Marcia L. Buck

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.24.5.522.33352